Rhinonorm Comfort (Spray) Instructions for Use
Marketing Authorization Holder
Teva Pharmaceutical Industries, Ltd. (Israel)
Manufactured By
Merckle, GmbH (Germany)
ATC Code
R01AB06 (Xylometazoline in combination with other drugs)
Active Substances
Dexpanthenol (Rec.INN registered by WHO)
Xylometazoline (Rec.INN registered by WHO)
Dosage Forms
| Rhinonorm Comfort | Metered dose nasal spray 0.1 mg+5 mg/dose: 10 ml bottle | |
| Metered dose nasal spray 0.05 mg+5 mg/dose: 10 ml bottle |
Dosage Form, Packaging, and Composition
Metered dose nasal spray as a transparent, almost colorless solution.
| 1 dose | |
| Xylometazoline (as hydrochloride) | 0.1 mg |
| Dexpanthenol | 5 mg |
Excipients : sodium phosphate heptahydrate (disodium phosphate heptahydrate) – 0.0225 mg, potassium dihydrogen phosphate – 0.855 mg, purified water – 95.372 mg.
10 ml (90 doses) – polyethylene bottles (1) with a metered dose spray device – cardboard packs×.
× protective stickers may additionally be applied.
Metered dose nasal spray as a transparent, almost colorless solution.
| 1 dose | |
| Xylometazoline (as hydrochloride) | 0.05 mg |
| Dexpanthenol | 5 mg |
Excipients : sodium phosphate heptahydrate (disodium phosphate heptahydrate) – 0.0225 mg, potassium dihydrogen phosphate – 0.855 mg, purified water – 95.322 mg.
10 ml (90 doses) – polyethylene bottles (1) with a metered dose spray device – cardboard packs×.
× protective stickers may additionally be applied.
Clinical-Pharmacological Group
Vasoconstrictor drug for topical use in ENT practice
Pharmacotherapeutic Group
Drugs for the treatment of nasal diseases; decongestants and other drugs for topical use; sympathomimetics, combinations without corticosteroids
Pharmacological Action
Combined medicinal product for topical application.
Xylometazoline belongs to the group of topical vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes constriction of the blood vessels of the nasal mucosa, restores the patency of the nasal passages, and facilitates nasal breathing. The drug’s effect usually begins within a few minutes after application and lasts up to 10 hours.
Dexpanthenol is a B group vitamin – a derivative of pantothenic acid. Dexpanthenol is converted in the body into pantothenic acid, which is a component of coenzyme A and is involved in acetylation processes, carbohydrate and fat metabolism, and in the synthesis of acetylcholine, corticosteroids, and porphyrins; it stimulates the regeneration of the skin and mucous membranes, normalizes cellular metabolism, accelerates mitosis, and increases the strength of collagen fibers. It has a regenerating, metabolic, and weak anti-inflammatory effect.
Pharmacokinetics
Xylometazoline is practically not absorbed when applied topically; plasma concentrations are so low that they cannot be determined by modern analytical methods.
Dexpanthenol is rapidly absorbed through the skin when applied topically and is converted into pantothenic acid, which binds to plasma proteins (mainly to beta-globulin and albumin). Its concentration in blood is 0.5-1 mg/L, in blood serum – 100 µg/L. Pantothenic acid is not metabolized in the body (except for incorporation into CoA) and is excreted unchanged.
Indications
Acute respiratory diseases with symptoms of rhinitis; acute allergic rhinitis; vasomotor rhinitis; sinusitis; otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa); to facilitate rhinoscopy; to restore impaired nasal breathing after surgical interventions in the nasal cavity.
ICD codes
| ICD-10 code | Indication |
| H66 | Suppurative and unspecified otitis media |
| J00 | Acute nasopharyngitis (common cold) |
| J01 | Acute sinusitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.3 | Other allergic rhinitis (perennial allergic rhinitis) |
| J32 | Chronic sinusitis |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| AA9Z | Unspecified suppurative otitis media |
| CA00 | Acute nasopharyngitis |
| CA01 | Acute rhinosinusitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA08.00 | Allergic rhinitis due to pollen |
| CA08.03 | Other allergic rhinitis |
| CA08.3 | Vasomotor rhinitis |
| CA0A.Z | Chronic rhinosinusitis, unspecified |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For intranasal use only.
Administer 3-4 times per day into each nostril.
Limit the duration of treatment to a maximum of 5 days.
Do not exceed the recommended dosage or frequency of administration.
Before first use, prime the spray pump by pressing it several times until a fine mist is produced.
Before each application, gently blow your nose to clear the nasal passages.
Keep your head upright; do not tilt it backwards.
Close one nostril by pressing it with a finger.
Insert the tip of the spray into the open nostril.
Press down firmly on the pump while breathing in gently through your nose.
Repeat the procedure for the other nostril.
Wipe the spray tip clean after each use.
Discontinue use and consult a physician if symptoms persist or worsen after 5 days.
Avoid contamination of the spray tip by keeping it clean and not touching it with your fingers.
Adverse Reactions
With frequent and/or prolonged use: irritation and/or dryness of the nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion, allergic reactions, swelling of the nasal mucosa, vomiting, headache, dry rhinitis, palpitations, increased blood pressure, insomnia, visual disturbances, depression (with long-term use of high doses).
Contraindications
Arterial hypertension; tachycardia; severe atherosclerosis; atrophic rhinitis; hyperthyroidism; porphyria; prostatic hyperplasia; glaucoma; surgical interventions on the meninges (in history); children under 2 years of age; children under 6 years of age (for dosage forms intended for older children and adults); simultaneous therapy with MAO inhibitors and tricyclic antidepressants; hypersensitivity to the components of the medicinal product.
With caution
Diabetes mellitus, pheochromocytoma.
Use in Pregnancy and Lactation
Use during pregnancy and lactation (breastfeeding) is not recommended.
Pediatric Use
Contraindicated in children under 6 years of age.
Special Precautions
Before use, it is necessary to clean the nasal passages.
Should not be used for more than 5 days.
Effect on ability to drive vehicles and operate machinery
During the period of use, precautions should be observed, or driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions should be avoided.
Drug Interactions
With simultaneous use of MAO inhibitors and tricyclic antidepressants, an increase in systemic action is possible.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Kagocel pills 12mg, 30pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Ingavirin capsules 90mg, 10pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Arbidol, capsules 100mg, 40pcs
OKI, sachets 80mg 2g, 12pcs 